3353Newer P2Y12 inhibitors in a real-world setting: long-term outcomes from contemporary PCI with newer versus traditional dual antiplatelet regimes

3353Newer P2Y12 inhibitors in a real-world setting: long-term outcomes from contemporary PCI with newer versus traditional dual antiplatelet regimes

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European heart journal 2018-08, Vol.39 (suppl_1)
Hauptverfasser: Mohamed, M O, Amin, R T, McWilliams, N, Gerber, R T
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue suppl_1
container_start_page
container_title European heart journal
container_volume 39
creator Mohamed, M O
Amin, R T
McWilliams, N
Gerber, R T
description
doi_str_mv 10.1093/eurheartj/ehy563.3353
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1093_eurheartj_ehy563_3353</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1093_eurheartj_ehy563_3353</sourcerecordid><originalsourceid>FETCH-LOGICAL-c933-1fa3fa5501e29ecfba85d67d8fdecce6707f65b7c251ad5c69b5f7e04c6ce08b3</originalsourceid><addsrcrecordid>eNo9kE1OwzAQRi0EEqVwBCRfIK0d107CDlX8VKqgiy5gFTnOuHGVxNXYpeo9ODApRWxmZjF636dHyD1nE84KMYU9NqAxbqfQHKUSEyGkuCAjLtM0KdRMXpIR44VMlMo_rslNCFvGWK64GpHv0-8bHADpKv3kKXV94yoXPYbhpJoi6DY5eGxrGiBG128eaOv7TRIBO-r30fgOArXoO2p8H6HbedR4pKv5gh5cbGj_S_8CDPtAI-raRed73dJ6PwzdR7drdYQW4hC2cQPtllxZ3Qa4-9tjsn5-Ws9fk-X7y2L-uExMIUTCrRZWS8k4pAUYW-lc1iqrc1uDMaAyllklq8ykkutaGlVU0mbAZkYZYHklxkSesQZ9CAi23KHrhu4lZ-XJbPlvtjybLU-2xA83zXUX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>3353Newer P2Y12 inhibitors in a real-world setting: long-term outcomes from contemporary PCI with newer versus traditional dual antiplatelet regimes</title><source>Oxford Academic Journals (OUP)</source><source>Alma/SFX Local Collection</source><source>EZB*</source><creator>Mohamed, M O ; Amin, R T ; McWilliams, N ; Gerber, R T</creator><creatorcontrib>Mohamed, M O ; Amin, R T ; McWilliams, N ; Gerber, R T</creatorcontrib><identifier>ISSN: 0195-668X</identifier><identifier>EISSN: 1522-9645</identifier><identifier>DOI: 10.1093/eurheartj/ehy563.3353</identifier><language>eng</language><ispartof>European heart journal, 2018-08, Vol.39 (suppl_1)</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Mohamed, M O</creatorcontrib><creatorcontrib>Amin, R T</creatorcontrib><creatorcontrib>McWilliams, N</creatorcontrib><creatorcontrib>Gerber, R T</creatorcontrib><title>3353Newer P2Y12 inhibitors in a real-world setting: long-term outcomes from contemporary PCI with newer versus traditional dual antiplatelet regimes</title><title>European heart journal</title><issn>0195-668X</issn><issn>1522-9645</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNo9kE1OwzAQRi0EEqVwBCRfIK0d107CDlX8VKqgiy5gFTnOuHGVxNXYpeo9ODApRWxmZjF636dHyD1nE84KMYU9NqAxbqfQHKUSEyGkuCAjLtM0KdRMXpIR44VMlMo_rslNCFvGWK64GpHv0-8bHADpKv3kKXV94yoXPYbhpJoi6DY5eGxrGiBG128eaOv7TRIBO-r30fgOArXoO2p8H6HbedR4pKv5gh5cbGj_S_8CDPtAI-raRed73dJ6PwzdR7drdYQW4hC2cQPtllxZ3Qa4-9tjsn5-Ws9fk-X7y2L-uExMIUTCrRZWS8k4pAUYW-lc1iqrc1uDMaAyllklq8ykkutaGlVU0mbAZkYZYHklxkSesQZ9CAi23KHrhu4lZ-XJbPlvtjybLU-2xA83zXUX</recordid><startdate>20180801</startdate><enddate>20180801</enddate><creator>Mohamed, M O</creator><creator>Amin, R T</creator><creator>McWilliams, N</creator><creator>Gerber, R T</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20180801</creationdate><title>3353Newer P2Y12 inhibitors in a real-world setting: long-term outcomes from contemporary PCI with newer versus traditional dual antiplatelet regimes</title><author>Mohamed, M O ; Amin, R T ; McWilliams, N ; Gerber, R T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c933-1fa3fa5501e29ecfba85d67d8fdecce6707f65b7c251ad5c69b5f7e04c6ce08b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohamed, M O</creatorcontrib><creatorcontrib>Amin, R T</creatorcontrib><creatorcontrib>McWilliams, N</creatorcontrib><creatorcontrib>Gerber, R T</creatorcontrib><collection>CrossRef</collection><jtitle>European heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohamed, M O</au><au>Amin, R T</au><au>McWilliams, N</au><au>Gerber, R T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>3353Newer P2Y12 inhibitors in a real-world setting: long-term outcomes from contemporary PCI with newer versus traditional dual antiplatelet regimes</atitle><jtitle>European heart journal</jtitle><date>2018-08-01</date><risdate>2018</risdate><volume>39</volume><issue>suppl_1</issue><issn>0195-668X</issn><eissn>1522-9645</eissn><doi>10.1093/eurheartj/ehy563.3353</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0195-668X
ispartof European heart journal, 2018-08, Vol.39 (suppl_1)
issn 0195-668X
1522-9645
language eng
recordid cdi_crossref_primary_10_1093_eurheartj_ehy563_3353
source Oxford Academic Journals (OUP); Alma/SFX Local Collection; EZB*
title 3353Newer P2Y12 inhibitors in a real-world setting: long-term outcomes from contemporary PCI with newer versus traditional dual antiplatelet regimes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A32%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=3353Newer%20P2Y12%20inhibitors%20in%20a%20real-world%20setting:%20long-term%20outcomes%20from%20contemporary%20PCI%20with%20newer%20versus%20traditional%20dual%20antiplatelet%20regimes&rft.jtitle=European%20heart%20journal&rft.au=Mohamed,%20M%20O&rft.date=2018-08-01&rft.volume=39&rft.issue=suppl_1&rft.issn=0195-668X&rft.eissn=1522-9645&rft_id=info:doi/10.1093/eurheartj/ehy563.3353&rft_dat=%3Ccrossref%3E10_1093_eurheartj_ehy563_3353%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true